In the past year, the Commission has invested €226 million through the European Innovation Council pilot and the European Institute of Innovation and Technology to support innovative start-ups, small and medium-sized businesses (SMEs) and projects to develop solutions in the fight against the coronavirus pandemic and the ensuing crisis. Many of these companies and projects have already generated promising results.
Do not miss the Open Market Consultation on 22-23 March 2021 of the H2020 Pre-Commercial Procurement of Instand-NGS4P regarding integrated and standardized Next Generation Sequencing workflows for personalised therapy.
The new EBEAM project works on expanding the energy and spatial resolution of electron microscopy and demonstrating new applications in multiple disciplines, such as life sciences and quantum technology.
HySolChem is developing an innovative, low-cost reactor for capturing greenhouse gases and producing high value fuels and chemicals, while contextually removing harmful pollutants from wastewater. And all of this with photosynthesis.
The EU Horizon 2020 OPTOMICS project will develop and validate a digital-twin model, which aims at developing non-invasive and inexpensive prognostic and treatment planning methods for type-2 diabetes patients.
Today, the Commission presented a Communication for the proposed launch of a European bio-defence preparedness programme called “HERA Incubator” to address the emerging threat of coronavirus variants. Plans include important new research investments, mobilising an additional €30 million from Horizon 2020 to be complemented by a further €120 million from Horizon Europe.
The projects, which succeeded in the FET Proactive Emerging Paradigms and Communities call (FETPROACT-EIC-07-2020), subtopic A: Artificial Intelligence for extended social interaction, have set a collaboration agreement to strengthen dissemination and impact of project results
Neurotwin is a new EIC Pathfinder project that will build a computational framework to represent the mechanisms of interaction of electric fields with personalized brain networks and assimilate neuroimaging data in order to design personalized optimization strategies to treat Alzheimer’s disease.